Efficacy and safety of semaglutide: real-world tertiary care experience from Saudi Arabia
BACKGROUND: Semaglutide, a glucagon-like peptide-1, is an effective antidiabetic drug promoting weight loss and providing cardiovascular protection. The original trials did not include participants from Saudi Arabia; hence, the study's findings are expected to be useful. OBJECTIVES: Explore the effi...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
King Faisal Specialist Hospital and Research Centre
2024-11-01
|
| coleção: | Annals of Saudi Medicine |
| Acesso em linha: | http://www.annsaudimed.net/doi/10.5144/0256-4947.2024.361 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|